🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Synthesis and Antibacterial Activity of Bis-[1-(Adamantan-1-Yl)Ethyl]Amine Hydrochloride


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

An impurity in rimantadine hydrochloride drug substance that was previously undescribed in regulatory documents and the literature was identified. Its structure was elucidated and confirmed by a convergent synthesis. A method for synthesizing bis-[1-(adamantan-1-yl)ethyl]amine hydrochloride under laboratory conditions was developed. The antibacterial activity of the synthesized compound was assessed.

About the authors

V. I. Krylov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

S. V. Moiseev

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Author for correspondence.
Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

A. A. Kutin

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

N. G. Sakhno

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

O. V. Gunar

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

V. A. Yashkir

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

V. A. Merkulov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Public Health of the Russian Federation

Email: MoissevSV@expmed.ru
Russian Federation, Moscow, 127051

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Springer Science+Business Media New York